Extracorporeal shockwave therapy (ESWT) is a technology that was first introduced into clinical practice in 1982 for urologic conditions. Subsequent clinical applications in musculoskeletal conditions have been described in treatment of plantar fasciopathy, both upper and lower extremity tendinopathies, greater trochanteric pain syndrome, medial tibial stress syndrome, management of nonunion fractures, and joint disease including avascular necrosis. The aim of this review is to summarize the current understanding of treatment of musculoskeletal conditions with ESWT, accounting for differences in treatment protocol and energy levels. Complications from ESWT are rare but include 2 reported cases of injury to bone and Achilles tendon rupture in older adults using focused shockwave. Collectively, studies suggest ESWT is generally well-tolerated treatment strategy for multiple musculoskeletal conditions commonly seen in clinical practice.
Introduction
Extracorporeal shockwave therapy (ESWT) was first introduced into clinical practice in 1982 for urinary stone lithotripsy [1] . This technology revolutionized the approach to nephrolithiasis management, and quickly became adopted as a first-line, noninvasive, and effective method for treatment of urinary stones [2] . Soon thereafter, ESWT was studied in Orthopedics, as it was hypothesized that ESWT could loosen the cement in total hip arthroplasty revisions [3] . Animal studies conducted in the 1980s revealed that not only could shockwaves disturb the bone-cement interface [4] but also found an osteogenic response and improved fracture healing [5] . Although there is continued evidence for the use of ESWT for fracture healing [6] , the majority of orthopedic research has focused on ESWT for treatment of upper and lower extremity tendinopathies, fasciopathies, and soft tissue conditions.
Shockwave was first studied in the treatment of plantar fasciitis in 1996 [7] . The application was subsequently studied for upper extremity conditions, including lateral epicondylitis [8, 9] and rotator cuff tendinopathy [10] , as well as lower extremity conditions, including Achilles tendinopathy [11] , patellar tendinopathy [12] , hamstring tendinopathy [13] , and greater trochanteric pain syndrome (GTPS) [14, 15] .
Despite the study of ESWT for more than 3 decades, no standardized protocol exists for the treatment of musculoskeletal conditions. Several variables differ between research studies, including energy flux density (EFD), number of impulses, type of wave (focused or radial), device used, number of treatment sessions, days between sessions, area of application, and use of analgesia during application. Additionally, research protocols vary in recommendations for activity restriction after treatment and the adjuvant treatment with physical therapy, eccentric loading, stretching, and use of nonsteroidal anti-inflammatory drugs (NSAIDs). There is also variation in the definition of conservative treatment, the outcome measures, and length of follow-up among studies. Pain is the primary endpoint for most investigations, with few other outcome measures reported.
The clinical application of ESWT has been a controversial issue in the past, because of the mixed results in research studies. However, there is a mounting body of literature that appears to suggest that ESWT may be effective in treating a subset of chronic tendon and plantar fascia diseases for a subset of patients [16] . The purpose of this review is to synthesize the current available research on the use of ESWT for management of upper and lower extremity musculoskeletal conditions and identify best evidence for treatment.
Physiology of Extracorporeal Shockwave Therapy
Shockwaves are sound waves that have certain physical characteristics, including nonlinearity, high peak pressure followed by low tensile amplitude, short rise time, and short duration (10 ms). These characteristics generate a positive and negative phase of shockwave. The positive phase produces direct mechanical forces, whereas the negative phase generates cavitation and gas bubbles that subsequently implode at high speeds, generating a second wave of shockwaves [17] . When compared to ultrasound waves, the shockwave peak pressure is approximately 1000 times greater than the peak pressure of an ultrasound wave [16] .
Focused shockwave therapy and radial shockwave therapy are 2 types of shockwave therapy used in clinical practice. Focused shockwaves are generated by electrohydraulic, electromagnetic, and piezoelectric devices. Radial shockwaves are typically produced by pneumatic/ballistic devices [17] . Much of the early research in ESWT for musculoskeletal conditions utilized focused shockwave therapy [17] . Focused shockwaves have higher energy and generate maximal force at a selected depth, whereas radial shockwaves are lower energy and generate highest pressure at the skin surface with subsequent weakening at greater depth [18] .
Ioppolo defined energy flux density as the energy per impulse at the focal point of the shockwave [19] . In a study by Rompe et al in 1998 , the authors classified high EFD as 0.6 mJ/mm 2 , medium as 0.28 mJ/mm 2 , and low as 0.08 mJ/mm 2 [20] . In this study, the high energy flux application to tendon in an animal model led to persistent histopathologic changes, including inflammation, necrosis, and disorganized fibrocysts. Based on these findings, the authors suggested energy levels exceeding 0.28 mJ/mm 2 may not be appropriate for clinical use in tendon disorders [20] .
Mechanism of Action/Theoretical Application in Humans
The effects of ESWT treatment are unknown. Proposed mechanisms of action for ESWT include promoting neovascularization at the tendon-bone junction [21] , stimulating proliferation of tenocytes [22] and osteoprogenitor differentiation [23] , increasing leukocyte infiltration [20] , and amplifying growth factor and protein synthesis to stimulate collagen synthesis and tissue remodeling [22] [23] [24] [25] . ESWT may reduce pain through hyperstimulation of nociceptors/gate-control theory of pain transmission, altered pain receptor neurotransmission, and by increasing local pain-inhibiting substances [26] [27] [28] [29] . Stimulation of nociceptive C-fibers may not only play a role in analgesia, but also in tendon remodeling, as it may increase release of neuropeptides, causing fibroblast stimulation and vasodilation [30] . A list of additional proposed mechanisms of action of ESWT is included in Table 1 [31, 32] .
Methodology of Review
The conditions treated are divided into disease states. The primary articles were identified using PubMed search in September 2017 using a combination of the following search terms: shock wave therapy, ESWT, extracorporeal shockwave therapy, tendinopathy, and fasciopathy. The primary articles were used to identify additional articles by cross-reference. Because of limited total articles identified, we included both retrospective and prospective studies and noted whether studies included a control group, were blinded, and use of placebo. Additionally, the primary and secondary outcome measures for each study were reported.
Studies were each scored by 2 observers using Physiotherapy Evidence Database scale (PEDro) criterion to determine study quality [33] . A score that meets 7 of the 11 criteria has been described as high quality and externally valid in prior meta-analysis using this criterion [34] . All studies scored !7 with the exception of one study that scored 6 [35] . To quantify the type of shockwave treatment, study design, and protocol, studies included are listed in Tables 2-10 [36, 37] .
Subject Populations
Many of the studied musculoskeletal conditions are self-limiting diseases. As a result, most studies enrolled patients who had failed multiple conservative treatment options and were considered to have recalcitrant disease processes. Exclusion criteria in subjects often included local arthritis, generalized polyarthritis, rheumatoid arthritis, ankylosing spondylitis, reactive arthritis, nerve entrapments, prior surgeries at the site, pregnancy, infections, tumors, or use of systemic anticoagulation.
Lower Extremity Pathology

Plantar Fasciitis
Shockwave therapy has been studied in the treatment of plantar fasciitis since 1996, with favorable results initially reported in treatment of patients with plantar calcaneal spurs [7] . One early study demonstrating efficacy was a randomized controlled trial (RCT) by Kudo et al that examined 114 patients with a history of plantar fasciitis for 6 months or greater [36] . Investigators randomized patients to an active treatment group that would receive a single treatment session of ESWT or placebo. All patients were administered a medial calcaneal nerve block prior to ESWT or sham treatment. The ESWT flux density was incrementally increased to a "high-energy" density. At the 3-month endpoint, the ESWT population was found to have a statistically significant improvement in visual analog scale (VAS) pain scores and Roles-Maudsley scores as compared to the placebo group [36] .
Gollwitzer et al studied 246 patients with chronic plantar fasciitis [37] . Subjects were randomized to receive sham or ESWT at weekly intervals for 3 total sessions. The total EFD was uptitrated to 0.25 mJ/mm 2 with 500 introductory impulses, and thereafter treated with that energy for 2000 treatment impulses. Primary outcomes for treatment success included (A) percentage change in heel pain composite VAS score: composed of pain with first morning steps, pain during daily activities, and pain while applying standardized pressure, and (B) improvement in Roles-Maudsley score. At 12 weeks, the success rate of ESWT for pain reduction was 54.4% compared to 37.2% for the placebo group (P ¼ .0035, OR 2.015, number needed to treat 5.8) [37] .
Rompe et al conducted a randomized, single-blind study in 2015 in which patients were randomized to receive either 3 weekly sessions of low-energy radial shockwave, or combined treatment with ESWT and 8 weeks of a plantar fascia stretching program [38] . All patients received 2000 pulses with an EFD of 0.16 mJ/mm 2 , applied to the area of maximal tenderness. After receiving instructions and supervision, patients in the stretching group were asked to perform stretching exercises 3 times daily, for 8 weeks. Eight weeks after baseline assessment, both groups were observed to have improvements in pain; however, subjects instructed to stretch were noted to have greater improvement over those receiving ESWT as monotherapy. The outcomes in the stretching group remained improved up to 4 months, then became similar to those of the non-stretching group at 24 months [38] .
Three randomized-control trials did not demonstrate efficacy of ESWT over other treatments for management of chronic plantar fasciitis [39] [40] [41] . These 3 studies have been criticized because of methodology issues in treatment protocols [42] . Gollwitzer [37] reported favorable results for treatment of plantar fasciitis in a large RCT, and suggested use of local anesthesia (Haake), lower energy levels (Speed) , and anatomical landmarks rather than palpation guidance to direct treatment (Buchbinder) as potential issues in the protocols of the 3 RCTs. The use of local anesthesia prior to ESWT has been found to reduce the efficacy of treatment [43] . Compared to the Kudo study that reported a favorable response to ESWT with multiple treatments [36] , the active treatment group in the Speed study received a lower energy treatment (1500 pulses at 0.12 mJ/mm 2 ) or sham treatment for 3 total sessions administered on a monthly basis. The primary outcome was measured at 3 months following completion of treatment, with a positive response graded as a 50% improvement in VAS score. Seventeen (37%) patients in the active treatment group reported 50% improvement at 3 months, as compared to 10 (24%) of the sham treatment group (P ¼ .248, relative risk ¼ 0.827, 95% confidence interval [CI] 0.626-1.093) [40] .
Three meta-analyses were performed to evaluate the clinical response of plantar fasciitis to ESWT, each measuring different clinical outcomes. In 2005, Thomson et al [44] performed a meta-analysis examining 11 RCTs published between 1996-2003, including the 3 RCTs that did not demonstrate efficacy [39] [40] [41] . Two of the 11 trials did not require the patients to have had symptoms for greater than 6 months, and 3 of the trials used a low dose of ESWT as the control treatment. Outcome measures were obtained at 12 weeks posttreatment in all but 1 trial, which obtained outcome measures at 19 weeks. The pooled analysis from 6 trials Table 1 Proposed mechanisms of action for shockwave revealed a statistically significant but small treatment effect (P ¼ .04, 95% CI 0.02-0.83). The resulting reduced pain equated to a change on a 10-cm VAS, of less than a half-centimeter [44] .
In 2013, Dizon et al [34] performed a meta-analysis of 11 RCTs published between 1990-2010, all in subjects with heel pain for longer than 6 months. The studies were classified as using low-intensity (<0.1 mJ/mm 2 ), moderate intensity (0.1-0.2 mJ/mm 2 ), and highintensity shockwave (>0.2 mJ/mm 2 ). This review also included the RCTs by Haake, Buchbinder, and Speed [39] [40] [41] . The authors found that there was no difference in decreasing overall pain; however, a subgroup analysis revealed that moderate-intensity ESWT was effective in * The designation "not specified" was applied to studies that did not specify level of physical activity or sport of the population treated.
decreasing overall pain (P < .00001) and activity pain (P ¼ .001). ESWT was also found to be effective in decreasing morning pain (P ¼ .004) and increasing functional outcome (P ¼ .0001). The study data suggest that moderate-and high-intensity ESWT were superior to low-intensity ESWT in management of chronic plantar fasciitis [34] .
Lou et al [45] conducted a meta-analysis in 2017 that examined 9 RCTs published between 2001 and 2015. The investigators reported that in patients with chronic plantar fasciitis, 40.5%-60% had reduction in heel pain, 41.3%-60.8% had improvement in morning heel pain, and 49.6%-60% had improvement in heel pain during daily activities [45] . 
Achilles tendinopathy
Several studies have been conducted to evaluate the effectiveness of ESWT in treating Achilles tendinopathy. An initial study using focused ESWT delivered once monthly for 3 sessions did not detect differences in outcome [46] . Subsequent studies providing treatment on a weekly basis demonstrated favorable results. Rasmussen et al [47] assessed 48 patients with Achilles tendinopathy for greater than 12 weeks and randomized them to treatment with stretching and eccentric exercises and sham ESWT or ESWT. The intervention group received 4 weekly sessions of 2000 pulses (0.12-0.51 mJ/mm 2 ) radial shock waves. The primary outcomes measured included VAS for pain and American Orthopaedic Foot and Ankle Society Score (AOFAS). The patients were followed at intervals of 4, 8, and 12 weeks. Investigators reported a statistically significant increase in the AOFAS score of the intervention group, with best results measured at 8 and 12 weeks. Both groups reported reduced pain; however, these differences were not statistically significant.
Rompe conducted 2 studies assigning eccentric loading for the control group. For insertional Achilles tendinopathy, the control group was assigned the Alfredson protocol and compared to ESWT monotherapy. Superior pain relief and functional outcome with Victorian Institute of Sports Assessment (VISA-A) was measured for the ESWT group [48] , although the eccentric group did have improvement in symptoms. Notably, the eccentric loading program did not use the modified Alfredson protocol as it had not yet been described at the time of the study [49] . Additionally, the presence of a Haglund's deformity has been found to be associated with reduced outcome success for those treated with insertional Achilles tendinopathy [50] . In a separate study, Rompe et al [51] compared subjects with midportion Achilles tendinopathy randomized to ESWT plus eccentric loading to subjects who were assigned eccentric loading. ESWT combined with eccentric loading was found to yield greater improvement in pain and function as compared to eccentric loading alone at 4 months, though the groups had similar outcomes at a 1-year follow-up [51] .
In 2015, a systematic review was conducted on 11 studies evaluating the use of ESWT for Achilles tendinopathy. The authors concluded that ESWT demonstrated best evidence for short-term pain reduction and improved function compared to nonoperative treatment [52] . Of the studies included, 1 RCT found no difference between treatment arms [46] ; however, the authors of the review note that the subject population had an average age that was 10 years older on average for the ESWT group compared to the conservative group, and that this may have affected outcomes [52] .
Patellar Tendinopathy
In 2007, Vulpiani et al [12] performed a prospective study in 73 patients with patellar tendinopathy, consisting of treatment with an average of 4 weekly sessions of 1,500-2,500 impulses with energy varying from 0.08-0.44 mJ/mm 2 adjusted to pain tolerance. At the 1-month follow-up interval, 43.4% were found to benefit, 63.9% at 6-12 months, 68.8% at 13-24 months, and finally 79.7% at >24 months as defined by a scale created by the authors incorporating both improvement in pain on VAS and clinical improvement [12] .
Zwerver et al [53] conducted an RCT to assess the efficacy of ESWT in treating patellar tendinopathy in athletes who were actively competing, and found no benefit in this population with symptom duration less than 12 months. The patients received 3 weekly sessions of 2000 impulses with an EFD uptitrated to a maximum possible level of 0.58 mJ/mm 2 . The control group received the same treatment, with the exception that no applicator gel was placed. The primary outcome, as measured by the Victorian Institute of Sport AssessmentePatella (VISA-P) score, improved in both the control and treatment groups, and no significant difference between the groups was found at 1, 12, and 22 weeks. As opposed to the treatment protocol by Vulpiani, these athletes continued to participate in sport at their usual level without limitations on training. The authors suggest that ESWT is more effective in treating chronic patellar tendinopathy as opposed to the early stages of the disease process; however, they did not combine ESWT with standard conservative treatment, including eccentric loading. Additionally, the ESWT subjects were treated with energy levels exceeding the threshold that has been documented to contribute to tendon damage in animal model investigation [20] . In 2015, Mani-Babu et al [52] conducted a systematic review to evaluate the effectiveness of ESWT in treating patellar tendinopathy. The review included 5 studies consisting of 2 RCTs, 2 prospective trials and 1 retrospective trial. Overall, the results largely supported ESWT as a promising option for both short-and long-term treatment success [52] . A recent systematic review analyzed both surgical and nonsurgical treatment options available for treating patellar tendinopathy [54] . The authors concluded that treatment with ESWT should be considered following 6 months of nonsurgical treatment with eccentric exercises and physical therapy; however, ESWT may be considered for patients who are no longer progressing in physical therapy or those who do not want/ or are determined to be poor surgical candidates [54] .
Hamstring Tendinopathy
One published study to date has been conducted in ESWT for high hamstring tendinopathy and demonstrated favorable results. Cacchio et al [13] evaluated 40 patients with MRI-verified chronic proximal hamstring tendinopathy and randomized (N¼20 each group) each to ESWT or conservative treatment. Shockwaves were administered for 4 sessions at weekly intervals, of 2500 shocks with EFD of 0.18 mJ/mm 2 . The traditional conservative treatment group was treated with NSAIDs, followed by physical therapy, and finally an exercise program for a total of 6 weeks. The primary outcomes were a 3-point decrease on VAS score and a 2-phase decrease in the Nirschl phase rating scale evaluated at 1 week, 6 months, and 12 months after treatment. A larger reduction in both outcomes measures was observed at all time points for ESWT over conservative care. Of clinical relevance, 80% of the ESWT group could return to their pre-injury level of sport, as opposed to zero of the patients from conservative care. No major complications were reported in the ESWT group.
Greater Trochanteric Pain Syndrome (GTPS)
Furia et al [14] published a retrospective cohort study in 2009 examining 33 patients diagnosed with GTPS and symptoms for an average duration of 13.7 months. Each patient received a single session of 2000 shocks at 0.18 mJ/mm 2 . The primary outcome was measured using VAS scores, Harris Hip Scores, and Roles-Maudsley scores at 1, 3, and 12 months post-treatment. At each interval, subjects reported a statistically significant improvement in all outcome measures [14] .
Rompe et al [15] compared ESWT to corticosteroid injections and a home training program in patients with GTPS. Although a single palpation-guided corticosteroid injection targeting the greater trochanteric bursa and other painful regions yielded significantly better pain control at 1 month after intervention compared with ESWT and home training program, ESWT produced significantly better results at 4 months and 15 months after intervention [15] . 
Medial Tibial Stress Syndrome
Rompe et al [55] conducted a case-control study consisting of patients with medial tibial stress syndrome (MTSS) who were offered treatment with radial ESWT. All patients had symptoms for longer than 6 months and had imaging to exclude fracture. After being explained the side effects and cost, 49 of 127 subjects chose treatment with radial shockwave and a home training program, and of the remaining 78 subjects who chose the home training program alone, 47 were selected as controls by a blinded medical assistant. Each shockwave subject received 3 weekly low-energy treatments (EFD 0.1 mJ/mm 2 , total EFD 200 mJ/mm 2 ). The severity of pain as measured by a numeric rating scale was found to be significantly improved in the ESWT cohort at 1, 4, and 15 months. Fifteen months after treatment, 40 of the 47 patients in the ESWT group were able to return to their sport. In contrast, 22 of the 47 in the control group returned to sport. Additionally, patients in the ESWT group were more likely to state that they felt "completely recovered" or "much improved" at all 3 time points. In 2012, Moen et al [35] conducted a prospective control study of athletes with MTSS who were treated with either a running program or focused shockwave in combination with a running program. Five focused shockwave sessions were performed at weeks 1, 2, 3, 5, VISA-A ¼ Victorian Institute of Sports Assessment-Achilles tendinopathy; NRS ¼ numeric rating scale. * The designation "not specified" was applied to studies that did not specify level of physical activity or sport of the population treated. No significant difference between groups in VISA-P or VAS, no treatmenttime interaction effect. Only significant difference was subjective pain improvement 1 wk after final treatment in VAS et al [56] described treatment of 2 elite athletes diagnosed with MTSS, who were treated with ESWT and a graduated running protocol. The cases describe athletes who were able to continue participating in their sports safely, and in one case, one won an Olympic Gold Medal 17 weeks after treatment [56] .
Nonunions, Avascular Necrosis, Stress Fractures
Shockwave therapy for the treatment of conditions such as nonunions, stress fractures, and avascular necrosis appears to be more widely accepted outside of the United States than within the United States [6] . Furia et al [6] report that many trauma centers in Europe and Asia regularly use ESWT to treat nonunions. Birnbaum et al [57] examined 10 studies and concluded that though ESWT yielded high healing rates, 75%-91%, this treatment was to remain considered "experimental" as there were no prospective RCTs. Efficacy appears to depend on the type of bone-related pathology, differentiating between nonunion, atrophy, or hypertrophy [58, 59, 60] . Cacchio et al [61] published a prospective RCT that compared ESWT in treatment of long-bone nonunions to surgical treatment. ESWT was found to be comparable to surgery in healing long-bone nonunions. ESWT may be an effective treatment for nonunion, but optimal dose and protocol must still be established.
Wang et al [62] studied ESWT versus core decompression and grafting in patients with avascular necrosis of the femoral head. Twenty-five months after treatment, patients treated with ESWT had improved pain and Harris Hip Scores. At long-term follow-up, 76% of the patients treated with ESWT showed good or fair clinical outcomes, compared with 21% of the surgical treatment group [63] . Taki et al [64] reported 5 cases in which ESWT was used to expedite healing in refractory stress fracture, in which radiographic improvement was seen within 1-1.5 months after treatment, and radiographic consolidation between 1-3.5 months after treatment.
Upper Extremity Pathology
Lateral Epicondylitis
Initial studies on the effect of ESWT for management of lateral epicondylitis found little benefit over placebo treatment [8, 9, [65] [66] [67] . Some issues with these * The designation "not specified" was applied to studies that did not specify level of physical activity or sport of the population treated.
studies include use of local anesthesia [67] , monthly frequency of treatments with a short follow-up of 3 months [9] , low-dose ESWT as control treatment [65] , and inadequate description in chronicity of symptoms [8] .
In contrast, 2 studies have revealed a favorable response of ESWT for lateral epicondylitis. Pettrone and McCall [68] studied 114 patients with chronic lateral epicondylitis, as defined by symptoms for at least 6 months and failure of 2 conservative therapy treatments. The patients were randomized to receive ESWT for 3 weekly treatments (2000 impulses, EFD 0.06 mJ/mm 2 ) or sham treatment with a sound-reflecting pad between the head of the machine and the patient. At 12 weeks, patients in the placebo group could cross over into the active treatment group if they still met study criteria. At 12 weeks, there was a significant difference in pain reduction on the Thomsen test and on the VAS. There was a significant improvement in the upper extremity functional scores and patient activity scores in the treatment group at 12 weeks. Additionally, there was an improvement in grip strength in the treatment group, but this difference was not found to be significant (P ¼ .09). At 1 year, 93% of the active treatment group reported at least 50% reduction in pain. Patients who chose to cross over to ESWT had observed improved pain scores compared to their prior pain scores during placebo treatment. The benefits in pain reduction were durable for nearly all who received ESWT over 12 months' follow-up [68] . Similarly Rompe et al [69] performed an RCT examining the effect of 3 weekly sessions of low-dose ESWT (0.09 mJ/mm 2 ) versus placebo for treatment of chronic lateral epicondylitis, with the primary outcome of improved pain during the Thomsen test at 3 months. Though reduced pain was noted in both groups 3 months after completion of treatment, the ESWT group was found to have statistically significant improvement compared with the control group (95% CI 0.6-2.4; P ¼ .001). Twelve months post-treatment, the difference in pain reduction between groups persisted, but no longer remained significant.
In 2007, Rompe and Maffuli [70] conducted a systematic review of 10 studies that evaluated ESWT as treatment for lateral epicondylitis. Because of the clinical and methodologic heterogeneity, the results of the studies were not pooled for meta-analysis. The authors concluded that ESWT could be considered in restricted conditions only, and might yield improved outcomes in chronic recalcitrant cases. 
Tendinopathy of the Shoulder
The first reported study on noncalcific rotator cuff tendinopathy was by Speed et al [10] . Investigators compared active ESWT delivered with an EFD of 0.12 mJ/mm 2 to sham treatment (0.04 mJ/mm 2 , head deflated without coupling gel) for 3 treatments provided monthly. Both groups had improvements over 6 months, with investigators concluding that placebo benefits were seen in the use of ESWT for this condition [10] . Li et al [71] conducted a randomized, double-blind, placebo-controlled trial examining patients with chronic rotator cuff tendinitis without calcifications with symptoms for greater than 6 months. The intervention was 3000 pulses of radial shockwave and EFD of 0.11 mJ/mm 2 . Five total treatments were provided with each separated by 3 days. The outcomes were measured at 4 and 8 weeks after treatment, at which time all measures, pain by numeric rating scale, ConstantMurley Score (CMS), and Simple Shoulder Test, were significantly improved in the ESWT group over the control group [71] . Galasso et al [72] performed a doubleblind, randomized, placebo-controlled study on 20 patients with noncalcifying supraspinatus tendinopathy and found significantly improved CMS and ROM in the ESWT group as compared to the placebo group. Ioppolo et al [73] studied patients with calcific tendinitis of the supraspinatus tendon. Forty-six patients were randomized to either receive 4 weekly sessions of ESWT using 2400 pulses at 0.20 or 0.10 mJ/mm 2 , and a control group was not present. The outcomes in terms of CMS and pain score on VAS were measured at 3 and 6 months after treatment. Interval change in radiographic appearance of calcific deposits was evaluated 6 months post-treatment. Both groups were found to have improved outcomes at each time point; however, the VAS scores were statistically reduced and the CMS were higher at 6 months in the higher energy group (0.20 mJ/mm 2 ). The authors also noted that clinical improvement did not correlate with a reduction in size of calcifications [73] .
Bannuru et al [74] performed a systematic review examining 28 RCTs pooling 1745 patients with symptoms for 3-12 months. Patients with calcific and noncalcific tendinitis were included in this review. The authors found that high-energy ESWT (EFD > 0.28 mJ/mm 2 ) was successful in improving pain, function, and resorption of calcifications in patients with calcific tendinitis. Lowenergy ESWT was found to improve shoulder function in patients with calcific tendinitis; however, ESWT for treatment of noncalcific tendinitis at both high and low energy was not effective.
In 2017, Wu et al [75] examined 14 RCTs that evaluated several different treatment options for chronic calcific tendinitis of the shoulder, including high-energy FSWT, low-energy FSWT, radial shockwave, transcutaneous electrical nerve stimulation, and ultrasoundguided needling. They found that high-energy FSWT and radial shockwave were more effective than low-energy focused shockwave. Ultrasound-guided needling also appeared to produce beneficial results. Of all forms of ESWT, high-energy focused shockwave was found to be the best therapy for promoting functional recovery [75] .
Adverse Effects of ESWT
In all studies, common side effects after ESWT include transient pain, skin erythema, pain, and local swelling. Two case reports were found that noted bone injuries [76, 77] . The first described a patient who received ESWT for supraspinatus calcific tendinopathy, who showed improvement clinically and radiographically after treatment. Three years after treatment, she developed recurrent shoulder pain and was diagnosed with stage IV osteonecrosis of the humeral head. The authors of the case report mention that injury to the ascending branch of the anterior humeral circumflex artery may explain her presentation [76] . The second case involves a patient treated for plantar fasciitis with 2 sessions of ESWT within 10 days. After treatment, she noted worsening pain and greater difficulty ambulating. Her MRI revealed a linear calcaneal fracture that did not reach the opposite cortex. Three months later the fracture healed, and 12 months later her pain resolved [77] . A separate study identified 2 patients receiving focused shockwave who sustained Achilles tendon ruptures; both occurred within 2 weeks of treatment and were in older female patients ages 62 and 65 [46] .
Conclusion
ESWT may result in beneficial effects for treatment of patients with various refractory musculoskeletal conditions including disease of tendons and plantar fascia. Notably, studies did have mixed results for most conditions, and studies with favorable outcomes did not report consistent improvement for all patients receiving ESWT. Individual response to ESWT likely varies based on a number of factors. The optimal protocol, including EFD, number of impulses, device, type of shockwave, number of treatment sessions, interval between sessions, and adjuvant treatment must still be determined for each condition. In patients who have failed to respond adequately to conservative treatment options and are presented with surgery as the next choice, ESWT may be a reasonable alternative treatment option that could produce results comparable or superior to those with surgical treatment [61] .
Available literature would support use of low-energy radial shockwave treatment for most treatment applications mentioned in this review; focused high-energy shockwave appears to be more effective for calcific tendinopathy of the shoulder. The number of treatments varied between protocols; however, most studies demonstrating efficacy separated treatment by 1 week and provided a total of 3-5 treatment sessions. Not all protocols reported on the combined use of physical therapy. Philosophically, coupling ESWT to progressive physical therapy programs to restore tissue function may optimize response to treatment. Nerve block is not recommended during treatment according to available literature demonstrating poor outcomes when using anesthetics. Additionally, use of local analgesia may reduce the ability to use the clinical focusing technique to interactively identify sites of pathology and direct treatment. Additionally, NSAID use may be discouraged given the concern for disrupting normal inflammatory pathway that may be responsible for treatment response.
As physiatrists provide care to athletes and individuals with musculoskeletal and neurologic injuries, identifying effective treatments for pain is important to help facilitate function. Limitations in guiding use of ESWT include the small number of well-designed clinical trials to evaluate efficacy of treatment. Notably, few studies have evaluated athlete populations, and there are no recognized studies published to date in patients with underlying neurologic conditions or patients with non-musculoskeletal classes of disability. The studies evaluated in this review had low measured bias with exception of criteria of blinding the therapist administering placebo and treatment ESWT. Studies have created a variety of placebo ESWT conditions; however, the influence of not achieving complete blinding to comparative effectiveness cannot be determined. In addition to measures to optimize blinding of treatment, studies are needed to compare ESWT to other interventions for treatment of tendon and ligament diseases, including platelet-rich plasma, tenotomy, and other treatments. Postprocedure guidelines do not currently exist to guide patients on appropriate graded return to exercise for most conditions following ESWT. Additionally, medical insurance and healthcare delivery in the United States does not routinely reimburse for ESWT treatment, creating a financial barrier. Despite these limitations, the current evidence does suggest ESWT may be a reasonable treatment to consider for management of chronic musculoskeletal conditions that fail to respond to conservative care given favorable safety profile and low risk for side effects.
